Fenofibrate Decreases Ethanol-Induced Neuroinflammation and Oxidative Stress and Reduces Alcohol Relapse in Rats by a PPAR-α-Dependent Mechanism

Fenofibrate Decreases Ethanol-Induced Neuroinflammation and Oxidative Stress and Reduces Alcohol Relapse in Rats by a PPAR-α-Dependent Mechanism

High ethanol consumption triggers neuroinflammation, implicated in sustaining chronic alcohol use. This inflammation boosts glutamate, prompting dopamine release in reward centers, driving prolonged drinking and relapse. Fibrate drugs, activating peroxisome proliferator-activated receptor alpha (PPA...

Full description

Bibliographic Details
Main Authors:	Cristina Ibáñez, Tirso Acuña, María Elena Quintanilla, Diliana Pérez-Reytor, Paola Morales, Eduardo Karahanian
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Series:	Antioxidants
Subjects:	alcohol use disorder alcoholism fibrates neuroinflammation PPAR alpha
Online Access:	https://www.mdpi.com/2076-3921/12/9/1758

Similar Items

Fenofibrate (a PPAR-α Agonist) Administered During Ethanol Withdrawal Reverts Ethanol-Induced Astrogliosis and Restores the Levels of Glutamate Transporter in Ethanol-Administered Adolescent Rats
by: Francisca Villavicencio-Tejo, et al.
Published: (2021-04-01)

Fenofibrate Administration Reduces Alcohol and Saccharin Intake in Rats: Possible Effects at Peripheral and Central Levels
by: Mario Rivera-Meza, et al.
Published: (2017-07-01)

Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet
by: Ying Zhang, et al.
Published: (2022-09-01)

Fibrane the reduced derivative of fenofibrate
by: Amanda E. Kotheimer, et al.
Published: (2020-01-01)

Effects of fenofibrate on lipid parameters in obese rhesus monkeys
by: Deborah A. Winegar, et al.
Published: (2001-10-01)

Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
by: Songling Jiang, et al.
Published: (2022-11-01)

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
by: Claudia Sagheddu, et al.
Published: (2021-10-01)

PPAR agonists for the treatment of primary biliary cholangitis: Old and new tales
by: Francesca Colapietro, et al.
Published: (2023-01-01)

Alcohol-Induced Headache with Neuroinflammation: Recent Progress
by: He Zhu, et al.
Published: (2023-02-01)

Chronic Low-Dose Alcohol Consumption Attenuates Post-Ischemic Inflammation via PPARγ in Mice
by: Chun Li, et al.
Published: (2021-05-01)

The Small Molecule PPARγ Agonist GL516 Induces Feeding-Stimulatory Effects in Hypothalamus Cells Hypo-E22 and Isolated Hypothalami
by: Annalisa Chiavaroli, et al.
Published: (2022-07-01)

Effect of <em>CYP3A4</em>*22 and <em>PPAR-α</em> Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention
by: Thomas O. Bergmeijer, et al.
Published: (2020-09-01)

Activation of Melanocortin-4 Receptor Inhibits Both Neuroinflammation Induced by Early Exposure to Ethanol and Subsequent Voluntary Alcohol Intake in Adulthood in Animal Models: Is BDNF the Key Mediator?
by: Osvaldo Flores-Bastías, et al.
Published: (2020-01-01)

Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse
by: Laura Orio, et al.
Published: (2019-01-01)

Implication of the PTN/RPTPβ/ζ Signaling Pathway in Acute Ethanol Neuroinflammation in Both Sexes: A Comparative Study with LPS
by: María Rodríguez-Zapata, et al.
Published: (2023-04-01)

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Substance Use Disorders: A Synthesis of Preclinical and Human Evidence
by: Justin Matheson, et al.
Published: (2020-05-01)

PPAR-α Hypermethylation in the Hippocampus of Mice Exposed to Social Isolation Stress Is Associated with Enhanced Neuroinflammation and Aggressive Behavior
by: Francesco Matrisciano, et al.
Published: (2021-10-01)

Reduced gut microbiome protects from alcohol-induced neuroinflammation and alters intestinal and brain inflammasome expression
by: Patrick P. Lowe, et al.
Published: (2018-10-01)

Gene specific modifications unravel ethanol and acetaldehyde actions
by: YEDY eISRAEL, et al.
Published: (2013-07-01)

Expression of Toll-like receptors in emotiogenic structures of rat brain is changed under longterm alcohol consumption and ethanol withdrawal
by: M. I. Airapetov, et al.
Published: (2020-01-01)

Rosiglitazone regulates astrocyte polarization and neuroinflammation in a PPAR-γ dependent manner after experimental traumatic brain injury
by: Xu Ren, et al.
Published: (2024-04-01)

Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats
by: Ana Soria, et al.
Published: (2002-01-01)

Glial modulation by N-acylethanolamides in brain injury and neurodegeneration
by: María Inés Herrera, et al.
Published: (2016-04-01)

Genistein Modulated Lipid Metabolism, Hepatic PPARγ, and Adiponectin Expression in Bilateral Ovariectomized Rats with Nonalcoholic Steatohepatitis (NASH)
by: Sudaporn Pummoung, et al.
Published: (2020-12-01)

Design and synthesis of guaiacol-based fibrate derivatives with potential hypolipidemic and liver protective actions
by: Yan Zhang, et al.
Published: (2024-01-01)

Prior Binge Ethanol Exposure Potentiates the Microglial Response in a Model of Alcohol-Induced Neurodegeneration
by: Simon Alex Marshall, et al.
Published: (2016-05-01)

24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ
by: Christoph Grander, et al.
Published: (2023-11-01)

Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis
by: Emerson de Andrade Lima, et al.
Published: (2013-12-01)

Induction of Tissue Factor Expression in Endothelial Cells by Basic Fibroblast Growth Factor and its Modulation by Fenofibric acid
by: Hamada Junichi, et al.
Published: (2003-10-01)

Magnolol Prevents Acute Alcoholic Liver Damage by Activating PI3K/Nrf2/PPARγ and Inhibiting NLRP3 Signaling Pathway
by: Xiao Liu, et al.
Published: (2019-12-01)

PPAR-Targeted Therapies in the Treatment of Non-Alcoholic Fatty Liver Disease in Diabetic Patients
by: Naomi F. Lange, et al.
Published: (2022-04-01)

The lack of PPARα exacerbated the progression of non-alcoholic steatohepatitis in mice with spleen deficiency syndrome by triggering an inflammatory response
by: Jiawen Huang, et al.
Published: (2024-04-01)

Loss of Dec1 inhibits alcohol-induced hepatic lipid accumulation and circadian rhythm disorder
by: Fuyuki Sato, et al.
Published: (2024-01-01)

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
by: Tarantino N, et al.
Published: (2017-02-01)

Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial
by: Behzad Hatami, et al.
Published: (2022-08-01)

PPAR Gamma and Viral Infections of the Brain
by: Pierre Layrolle, et al.
Published: (2021-08-01)

Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion
by: Shigeki Kitamura, et al.
Published: (2023-09-01)

Stevia and Stevioside Attenuate Liver Steatosis through PPARα-Mediated Lipophagy in <i>db/db</i> Mice Hepatocytes
by: Miey Park, et al.
Published: (2022-12-01)

Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis
by: Huiling Wei, et al.
Published: (2023-04-01)

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?
by: Tenenbaum Alexander, et al.
Published: (2012-11-01)